10th Oct 2013 07:06
LONDON (Alliance News) - Immunodiagnostic Systems Holdings PLC said in a trading update Thursday that it expects revenues for the half-year ended September 30 will be GBP27 million, a 13% growth from GBP24 million in the previous year, driven by growth in automated revenues.
The company said that although automated revenues had grown, manual revenues declined by 14% compared to the previous year. It expects pre-exceptional profit to be in line with the previous year.
Direct placements are instruments placed or sold with rental end-user customers in its core markets. Its direct placements in the first-half were 16, compared to 41 in the previous year. However, the company suggested its second half direct placements will pick up materially over the first half.
The clinical and research diagnostic testing kits company will announces its interim results on November 27.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
IDH.L